Soyoung Park Selected Research

Disinfectants (Biocides)

4/2022	Review of Inhalation Health Risks Involving Chloromethylisothiazolinone (CMIT) and Methylisothiazolinone (MIT) Used as Disinfectants in Household Humidifiers.
7/2021	Characteristics of the Molecular Weight of Polyhexamethylene Guanidine (PHMG) Used as a Household Humidifier Disinfectant.
1/2021	Need for individual-based evaluation to determine the association between humidifier disinfectants and health injuries.
1/2021	Erratum: Need for individual-based evaluation to determine the association between humidifier disinfectants and health injuries.
11/2020	Comparison of Long Term Follow-up Chest CT Imaging in Adult and Pediatric Patients with Humidifier Disinfectant-related Lung Injury.
11/2020	Characteristics of Exposure to Chloromethylisothiazolinone (CMIT) and Methylisothiazolinone (MIT) among Humidifier Disinfectant-Associated Lung Injury (HDLI) Patients in South Korea.
10/2020	Characteristics of a new respiratory syndrome associated with the use of a humidifier disinfectant: humidifier disinfectant-related respiratory syndrome (HDRS).
9/2020	Recommendation for the establishment of a poison control center at the Korea Disease Control and Prevention Agency.
1/2019	Humidifier disinfectant and use characteristics associated with lung injury in Korea.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Soyoung Park Research Topics

Disease

16	Obesity 01/2021 - 02/2012
11	Neoplasms (Cancer) 05/2022 - 12/2012
8	Lung Injury 04/2022 - 01/2019
8	Body Weight (Weight, Body) 11/2020 - 02/2012
4	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022 - 01/2016
4	Type 2 Diabetes Mellitus (MODY) 04/2021 - 01/2018
4	Insulin Resistance 04/2021 - 01/2018
3	Progeria (Hutchinson Gilford Syndrome) 01/2022 - 01/2021
3	Wounds and Injuries (Trauma) 03/2021 - 01/2021
3	Drug Resistant Epilepsy 01/2020 - 06/2017
2	Breast Neoplasms (Breast Cancer) 04/2022 - 01/2018
2	Atrophy 01/2021 - 10/2019
2	Hyperglycemia 01/2021 - 01/2018
2	Abdominal Obesity 01/2021 - 01/2019
2	Hypertension (High Blood Pressure) 01/2021 - 01/2019
2	Seizures (Absence Seizure) 10/2020 - 09/2014
2	Neoplasm Metastasis (Metastasis) 04/2020 - 01/2017
2	Tuberous Sclerosis (Bourneville's Disease) 01/2020 - 06/2017
2	Epilepsy (Aura) 01/2020 - 06/2017
2	Overweight 01/2019 - 02/2012
2	Hypoxia (Hypoxemia) 01/2019 - 01/2017
2	Lung Neoplasms (Lung Cancer) 01/2017 - 01/2016
2	Carcinogenesis 01/2017 - 02/2016
2	Papillary Thyroid Cancer 03/2013 - 02/2012
2	Inflammation (Inflammations) 12/2012 - 02/2012
1	Adenocarcinoma of Lung 05/2022
1	Colonic Neoplasms (Colon Cancer) 05/2022
1	Neurofibrosarcoma (MPNST) 03/2022
1	Neurofibromatosis 2 (Neurofibromatosis Type II) 03/2022
1	Bites and Stings (Sting) 12/2021
1	Fanconi Anemia (Fanconi's Anemia) 12/2021
1	Neuroblastoma 12/2021
1	Hypertriglyceridemia 01/2021
1	Immune System Diseases (Immune Disorders) 01/2021
1	Hypersensitivity (Allergy) 01/2021
1	Hemolysis 01/2021
1	Asthma (Bronchial Asthma) 01/2021
1	Peptic Esophagitis (Reflux Esophagitis) 01/2021
1	Werner Syndrome (Werner's Syndrome) 01/2021
1	Weight Loss (Weight Reduction) 01/2021
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2021
1	Stomach Neoplasms (Stomach Cancer) 04/2020

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 05/2022 - 06/2010
9	Disinfectants (Biocides)IBA 04/2022 - 01/2019
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2017
4	Pharmaceutical PreparationsIBA 05/2022 - 01/2018
4	LipidsIBA 01/2018 - 02/2012
3	EnzymesIBA 05/2022 - 02/2012
3	CarcinogensIBA 01/2022 - 01/2016
3	AntioxidantsIBA 04/2021 - 02/2012
3	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 11/2020 - 01/2019
3	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 01/2018
2	2-methyl-4-isothiazolin-3-oneIBA 04/2022 - 11/2020
2	Lamin Type A (Lamin A)IBA 03/2021 - 01/2021
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2021 - 01/2018
2	Therapeutic UsesIBA 10/2020 - 01/2018
2	LeptinIBA 01/2020 - 01/2020
2	trans-sodium crocetinate (crocetin)IBA 01/2020 - 06/2017
2	Triglycerides (Triacylglycerol)IBA 01/2019 - 01/2017
2	Phosphotransferases (Kinase)IBA 11/2018 - 01/2017
2	Insulin (Novolin)FDA Link 01/2018 - 01/2018
2	Deubiquitinating EnzymesIBA 01/2017 - 01/2017
2	UbiquitinIBA 01/2017 - 01/2017
2	Peptide Nucleic AcidsIBA 03/2013 - 02/2012
1	Tryptophan (L-Tryptophan)FDA Link 05/2022
1	kynureninaseIBA 05/2022
1	KynurenineIBA 05/2022
1	Adenosine Triphosphate (ATP)IBA 05/2022
1	Purinergic Receptors (Receptors, Purine)IBA 05/2022
1	SeleniumIBA 05/2022
1	Purinergic P2 Receptors (ADP Receptor)IBA 05/2022
1	Oxidoreductases (Dehydrogenase)IBA 04/2022
1	Lysine (L-Lysine)FDA Link 04/2022
1	ChitosanIBA 04/2022
1	Monoclonal AntibodiesIBA 04/2022
1	Neurofibromin 2 (Merlin)IBA 03/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Mitochondrial DNA (mtDNA)IBA 12/2021
1	Guanidine (Guanidine Nitrate)FDA Link 07/2021
1	CelluloseIBA 03/2021
1	LigninIBA 03/2021
1	methylallyl trisulfide (MATS)IBA 03/2021
1	3-nitrotyrosineIBA 01/2021
1	DNA HelicasesIBA 01/2021
1	CPG-oligonucleotideIBA 01/2021
1	CytosineIBA 01/2021
1	ORALIT (ORS)IBA 01/2021
1	Orlistat (Xenical)FDA Link 01/2021
1	HDL CholesterolIBA 01/2021
1	CarbohydratesIBA 01/2021
1	GuanineIBA 01/2021
1	Phospholipases (Phospholipase)IBA 01/2021
1	Phosphates (Orthophosphate)IBA 01/2021
1	OligodeoxyribonucleotidesIBA 01/2021

Therapy/Procedure

9	Humidifiers 04/2022 - 01/2019
7	Therapeutics 05/2022 - 11/2012
3	Ketogenic Diet 01/2020 - 06/2017
1	Gastrectomy 04/2020
1	Adjuvant Chemotherapy 04/2020
1	Drug Therapy (Chemotherapy) 04/2020